Vincent Medical Holdings Limited provided unaudited consolidated earnings guidance for the six months ended 30 June 2021. The company the profit attributable to owners of the company for the Period is expected to decrease by around 55.0%, as compared to HKD 91.8 million for the six months ended 30 June 2020. Such decrease was mainly caused by: (i) Reduction in revenue due to the absence of one-time COVID-19 related orders With the rollout of global vaccination campaign, along with the rationalization of medical device supply chain in 2021, demand for respiratory devices were returned to a normal level when comparing with the panic buying and national stock piling of medical supplies that the Group observed in 2020. Nevertheless, the drop in revenue from the respiratory products segment is partially offset by the recovery of the orthopaedic and rehabilitation products segment, as well as the steady growth in the imaging disposable products segment. It is worth noting that the revenue for the Period was 50.4% higher than that of the corresponding period in 2019, before the COVID-19 pandemic.